Semaglutide has undergone extensive clinical trials and has been approved by the Food and Drug Administration (FDA) for weight loss use
Routine blood work isnt merely useful
Increased risk of genitourinary infections, including Fourniers gangrene UTIs and other genital infections, including thrush or balanitis, can occur more frequently in patients taking empagliflozin
Patients receive HSA/FSA eligible prescriptions, and the flat monthly pricing means your dose can increase without price increasesa model designed around clinical needs, not profit from dose ladders
The LEADER trial (liraglutide), SUSTAIN-6 (semaglutide), and EXSCEL (exenatide) studies, which collectively followed thousands of patients for several years, did not report significant increases in fracture rates compared to placebo groups
It helps people stop the cycle of losing and gaining weight, so they can see lasting results